Nutritional composition and infant formula for promoting de novo myelination
AssigneeSociete des Produits Nestle S.A.
InventorsNora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai, Jonathan O'Regan
Life of this patent
Estimating the term…
Abstract
A synthetic nutritional composition comprising a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
Claims8
A method to reduce a risk of or mitigate sub-optimal de novo myelination trajectory in a formula fed infant up to 12 months of age, the method comprising administering to the formula fed infant a synthetic nutritional composition comprising sphingomyelin in an amount greater than 300 mg/kg dry weight of the synthetic nutritional composition.
Dependencies are inferred from the claim text.